For the Inventor, By the Inventor

Enter assignee name

Emeryville, CA, United States of America

Adamas Pharmaceuticals, Inc.

USPTO Granted Patents = 29

CIPO Patents = 2

EPO Patents = 6

Trademarks = 4

Forward Citations = 647

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Gregory T Went (26 out of 40 patents)

Timothy J Fultz (25 out of 44 patents)

Laurence R Meyerson (19 out of 21 patents)

4. Seth Porter (10 out of 15 patents)

5. Timothy S Burkoth (10 out of 12 patents)

6. David Chernoff (4 out of 6 patents)

7. Jack Nguyen (4 out of 5 patents)

8. Glenn A Meyer (2 out of 36 patents)

9. Sangita Ghosh (2 out of 5 patents)

10. Ana Cristina Pastini (2 out of 8 patents)

11. Marcelo Fernando Befumo (2 out of 8 patents)

12. Mickey S Urdea (2 out of 5 patents)

13. Paul Spence (2 out of 2 patents)

14. Rowan Chapman (2 out of 2 patents)

15. Terry L Burkoth (2 out of 25 patents)

29 patents: Sort by Forward Citations

1. 11890261 - Composition and method for treating neurological disease (2024-02-06),

2. 11833121 - Composition and method for treating neurological disease (2023-12-05),

3. 10987324 - Methods and compositions for the treatment of seizure-related disorders (2021-04-27),

4. 10973783 - Methods and compositions for the treatment of seizure-related disorders (2021-04-13),

5. 9072697 - Composition and method for treating neurological disease (2015-07-07),

6. 8987333 - Composition and method for treating neurological disease (2015-03-24),

7. 8895618 - Composition and method for treating neurological disease (2014-11-25),

8. 8895617 - Composition and method for treating neurological disease (2014-11-25),

9. 8895616 - Composition and method for treating neurological disease (2014-11-25),

10. 8895615 - Composition and method for treating neurological disease (2014-11-25),

11. 8895614 - Composition and method for treating neurological disease (2014-11-25),

12. 8889740 - Composition and method for treating neurological disease (2014-11-18),

13. 8741343 - Method of administering amantadine prior to a sleep period (2014-06-03),

14. 8580858 - Compositions for the treatment of CNS-related conditions (2013-11-12),

15. 8426472 - Method and composition for administering an NMDA receptor antagonist to a subject (2013-04-23),

Adamas Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients affected by chronic neurologic disorders. Their goal is to improve the lives of those impacted by neurologic conditions by providing treatment options that address unmet medical needs. Through their research and development efforts, Adamas Pharmaceutical is committed to advancing the field of neurology and transforming lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

29 Patents

#20 in Emeryville, CA

#2,687 in California

#11,235 in US

#21,869 in the World

Emeryville, CA, United States of America

Adamas Pharmaceuticals, Inc.

Forward Citations = 647

27 inventors:

Gregory T Went (26 out of 40 patents)

Timothy J Fultz (25 out of 44 patents)

Laurence R Meyerson (19 out of 21 patents)

4. Seth Porter (10 out of 15 patents)

5. Timothy S Burkoth (10 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…